Enfusion, Inc.
ENFNNYSETechnology
$10.76
$-0.04(-0.37%)
Market Cap$1.0B
P/E Ratio—
52W High$11.8
52W Low$7.83
Enfusion, Inc. (ENFN) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · ENFN · as of 2026-06-09
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2024-12 | 2023-12 | 2022-12 | 2021-12 | 2020-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $0.20B | $0.17B | $0.15B | $0.11B | $0.08B |
| Cost of Revenue | $0.06B | $0.06B | $0.05B | $0.03B | $0.02B |
| Gross Profit | $0.14B | $0.12B | $0.10B | $0.08B | $0.06B |
| Gross Margin %(computed) | 67.82% | 66.97% | 68.67% | 71.49% | 73.16% |
| Operating Expenses | |||||
| R&D Expenses | $0.03B | $0.02B | $0.02B | $0.15B | $0.01B |
| G&A Expenses | $0.08B | $0.06B | $0.07B | $0.15B | $0.04B |
| Total Operating Expenses | $0.13B | $0.10B | $0.12B | $0.36B | $0.05B |
| Operating Income | $0.01B | $0.01B | ($0.01B) | ($0.28B) | $0.01B |
| Operating Margin %(computed) | 3.05% | 6.85% | -7.96% | -246.99% | 7.63% |
| Interest Income | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Interest Expense | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Income Before Tax | $0.01B | $0.01B | ($0.01B) | ($0.28B) | $0.00B |
| Income Tax Expense | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Net Income | $0.00B | $0.01B | ($0.01B) | ($0.28B) | $0.00B |
| Net Margin %(computed) | 1.40% | 3.45% | -8.82% | -252.68% | 5.10% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $0.02 | $0.10 | $-0.16 | $-4.30 | $0.06 |
| Wtd Avg Shares | 0.09B | 0.09B | 0.09B | 0.07B | 0.06B |
| EBITDA | $0.01B | $0.02B | ($0.01B) | ($0.27B) | $0.01B |
| EBITDA Margin %(computed) | 3.05% | 12.57% | -3.57% | -243.43% | 10.51% |
Data source: Financial Modeling Prep · Last updated: 2026-06-09 · USD · B
Explore more Enfusion, Inc. data
About Enfusion, Inc. (ENFN) Income Statement
Enfusion, Inc. (ENFN) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2024, ENFN reported revenue of $0.20B, gross profit of $0.14B (gross margin 67.82%), and net income of $0.00B — a net profit margin of 1.40%.
Frequently asked questions
ENFN · 4 questionsEnfusion, Inc. (ENFN) reported revenue of $0.20B for 2024, up 15.5% year-over-year.
ENFN revenueENFN salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09